NO20030524L - Vaksine mot vertscelleassosiert herpesvirus - Google Patents

Vaksine mot vertscelleassosiert herpesvirus

Info

Publication number
NO20030524L
NO20030524L NO20030524A NO20030524A NO20030524L NO 20030524 L NO20030524 L NO 20030524L NO 20030524 A NO20030524 A NO 20030524A NO 20030524 A NO20030524 A NO 20030524A NO 20030524 L NO20030524 L NO 20030524L
Authority
NO
Norway
Prior art keywords
host cell
herpes virus
vaccine against
against host
associated herpes
Prior art date
Application number
NO20030524A
Other languages
English (en)
Other versions
NO20030524D0 (no
NO332621B1 (no
Inventor
Frank Fehler
Kaus Osterrieder
Original Assignee
Lohmann Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Animal Health Gmbh filed Critical Lohmann Animal Health Gmbh
Publication of NO20030524D0 publication Critical patent/NO20030524D0/no
Publication of NO20030524L publication Critical patent/NO20030524L/no
Publication of NO332621B1 publication Critical patent/NO332621B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20030524A 2000-08-03 2003-02-03 Vaksine mot Mareks sykdom, rekombinant genom fra Mareks sykdomsvirus samt anvendelse derav for fremstilling av medikamenter mot Mareks sykdom. NO332621B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00202757A EP1178111A1 (en) 2000-08-03 2000-08-03 Vaccination against host cell-associated herpesviruses
PCT/EP2001/008893 WO2002012288A2 (en) 2000-08-03 2001-08-01 Vaccination against host cell-associated herpesviruses

Publications (3)

Publication Number Publication Date
NO20030524D0 NO20030524D0 (no) 2003-02-03
NO20030524L true NO20030524L (no) 2003-04-03
NO332621B1 NO332621B1 (no) 2012-11-19

Family

ID=8171884

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030524A NO332621B1 (no) 2000-08-03 2003-02-03 Vaksine mot Mareks sykdom, rekombinant genom fra Mareks sykdomsvirus samt anvendelse derav for fremstilling av medikamenter mot Mareks sykdom.

Country Status (24)

Country Link
US (1) US9073979B2 (no)
EP (2) EP1178111A1 (no)
JP (1) JP4313036B2 (no)
KR (1) KR100633180B1 (no)
CN (2) CN1503843A (no)
AT (1) ATE412055T1 (no)
AU (2) AU9171601A (no)
BR (1) BRPI0112989B1 (no)
CA (1) CA2417923C (no)
CZ (1) CZ303904B6 (no)
DE (1) DE60136278D1 (no)
EA (1) EA010721B1 (no)
ES (1) ES2315306T3 (no)
HR (1) HRP20030147B1 (no)
HU (1) HU228262B1 (no)
IL (2) IL154250A0 (no)
MX (1) MXPA03001027A (no)
NO (1) NO332621B1 (no)
NZ (1) NZ524066A (no)
PL (1) PL207958B1 (no)
PT (1) PT1307565E (no)
UA (1) UA84667C2 (no)
WO (1) WO2002012288A2 (no)
ZA (1) ZA200300842B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1178111A1 (en) 2000-08-03 2002-02-06 Lohmann Animal Health GmbH & Co. KG Vaccination against host cell-associated herpesviruses
CA2558586A1 (en) * 2004-03-05 2005-09-15 The Research Foundation For Microbial Diseases Of Osaka University Recombinant varicella-zoster virus
US9273326B2 (en) 2004-04-30 2016-03-01 The Brigham And Women's Hospital, Inc. Tetracycline-regulated gene expression in HSV-1 vectors
US20080226677A1 (en) * 2004-05-06 2008-09-18 Yasuko Mori Recombinant virus vector for gene transfer into lymphoid cells
EP3756684A1 (en) 2009-05-22 2020-12-30 Genocea Biosciences, Inc. Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
WO2011079073A2 (en) 2009-12-21 2011-06-30 The Brigham And Women's Hospital, Inc. Herpes simplex virus vaccines
EP2643014A4 (en) * 2010-11-24 2015-11-11 Genocea Biosciences Inc HERPES SIMPLEX TYPE 2 VIRUS VACCINES: COMPOSITIONS AND METHODS FOR STIMULATING AN IMMUNE RESPONSE
EP2768964B1 (en) * 2011-10-21 2018-10-10 Intervet International B.V. Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens
EP2782597B1 (en) * 2011-11-23 2022-04-13 Genocea Biosciences, Inc. Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
CN105597095A (zh) * 2015-12-30 2016-05-25 暨南大学 一种应用微载体培养Vero细胞制备基因缺失减毒疫苗的方法
CN105561303B (zh) * 2015-12-30 2019-04-05 暨南大学 单纯疱疹病毒i型ul5基因缺失的dna疫苗的制备方法
CN105641692A (zh) * 2015-12-30 2016-06-08 暨南大学 单纯疱疹病毒ⅰ型基因重组减毒活疫苗及其制备方法
JP2019537555A (ja) 2016-09-28 2019-12-26 ジェノセア バイオサイエンシーズ， インコーポレイテッド ヘルペスを処置するための方法および組成物
WO2019020480A1 (en) * 2017-07-24 2019-01-31 INSERM (Institut National de la Santé et de la Recherche Médicale) ANTIBODIES AND PEPTIDES FOR TREATING HCMV RELATED DISEASES
BR112020012162A2 (pt) * 2017-12-20 2020-11-24 Intervet International B.V. diluente aprimorado para vacina contra alfa-herpesvírus associado à célula
WO2019152821A1 (en) 2018-02-05 2019-08-08 The Brigham And Women's Hospital, Inc. Recombinant herpes simplex virus-2 expressing glycoprotein b and d antigens

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959466A (en) * 1974-04-15 1976-05-25 The Wistar Institute Highly attenuated cytomegalovirus vaccine and production thereof
GB8821441D0 (en) 1988-09-13 1988-10-12 Animal Health Inst Viral vectors
EP0486106A3 (en) 1990-11-16 1992-12-23 Akzo N.V. Marek's disease virus vaccine
AU657144B2 (en) * 1991-07-09 1995-03-02 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Recombinant Marek's disease virus, process for preparing the same and vaccine containing the same
JP3675569B2 (ja) 1995-04-28 2005-07-27 日本ゼオン株式会社 組み換えウイルス及びそれよりなるワクチン
WO1997003187A2 (en) 1995-07-07 1997-01-30 Nippon Zeon Co., Ltd. Marek's disease virus genes and their use in vaccines for protection against marek's disease
US6306387B1 (en) * 1997-05-29 2001-10-23 The Research Foundation Of State University Of New York Antigen delivery system
DE19733364A1 (de) * 1997-08-01 1999-02-04 Koszinowski Ulrich H Prof Verfahren zur Klonierung eines großen Virusgenoms
AUPP684998A0 (en) * 1998-10-30 1998-11-26 Murdoch Institute for Research into Birth Defects Limited, The A method of recombination and agents useful for same
EP1038952A3 (en) 1998-12-09 2001-06-27 Pfizer Products Inc. Processes for preparation of Marek's Disease Virus using continuous avian cell lines
US6410222B1 (en) * 1998-12-14 2002-06-25 Juridical Foundation The Chemosero-Therapeutic Research Institute In ovo vaccination of marek's disease type I virus
US6299882B1 (en) 1999-04-09 2001-10-09 Schering Corporation UL54.5 of Marek's disease virus (MDV)
EP1178111A1 (en) 2000-08-03 2002-02-06 Lohmann Animal Health GmbH & Co. KG Vaccination against host cell-associated herpesviruses

Also Published As

Publication number Publication date
EP1307565A2 (en) 2003-05-07
US9073979B2 (en) 2015-07-07
PL365190A1 (en) 2004-12-27
HRP20030147B1 (en) 2011-10-31
US20030165537A1 (en) 2003-09-04
CA2417923A1 (en) 2002-02-14
CZ303904B6 (cs) 2013-06-19
EP1178111A1 (en) 2002-02-06
CA2417923C (en) 2010-06-29
BRPI0112989B1 (pt) 2015-09-08
HU228262B1 (en) 2013-02-28
IL154250A0 (en) 2003-09-17
EA200300215A1 (ru) 2003-08-28
PL207958B1 (pl) 2011-02-28
AU2001291716B2 (en) 2007-06-07
UA84667C2 (ru) 2008-11-25
WO2002012288A2 (en) 2002-02-14
AU2001291716B8 (en) 2002-02-18
NO20030524D0 (no) 2003-02-03
EA010721B1 (ru) 2008-10-30
KR100633180B1 (ko) 2006-10-11
CZ2003324A3 (cs) 2003-06-18
JP2004505993A (ja) 2004-02-26
ATE412055T1 (de) 2008-11-15
WO2002012288A3 (en) 2002-04-11
IL154250A (en) 2013-07-31
JP4313036B2 (ja) 2009-08-12
AU9171601A (en) 2002-02-18
PT1307565E (pt) 2009-01-28
DE60136278D1 (de) 2008-12-04
ES2315306T3 (es) 2009-04-01
HUP0302664A2 (hu) 2003-11-28
KR20030036657A (ko) 2003-05-09
CN102151333A (zh) 2011-08-17
BR0112989A (pt) 2003-09-09
HRP20030147A2 (en) 2005-04-30
NO332621B1 (no) 2012-11-19
NZ524066A (en) 2004-11-26
ZA200300842B (en) 2004-04-30
EP1307565B1 (en) 2008-10-22
CN1503843A (zh) 2004-06-09
MXPA03001027A (es) 2004-02-26
HUP0302664A3 (en) 2004-10-28

Similar Documents

Publication Publication Date Title
NO20030524D0 (no) Vaksine mot vertscelleassosiert herpesvirus
Mettenleiter Molecular biology of pseudorabies (Aujeszky's disease) virus
BR0014171A (pt) Composição
EP1298139A3 (en) Avian herpes virus-based recombinant infectious bursal disease vaccine
AU585126B2 (en) Recombinant herpes simplex viruses, vaccines and methods
ATE194657T1 (de) Bei einer transkomplementenden zellinie erzeugter defektiver virenimpfstoff
CA2166367A1 (en) Live recombinant avian vaccine using an avian herpesvirus as vector
WO1990002803A3 (en) Viral vaccines
BR0014172A (pt) Composição
AU3142889A (en) A recombinant marek's disease virus and a vaccine
EP0261940A3 (en) Pseudorabies vaccines and dna vectors for recombination with pox viruses
Field et al. Herpesvirus latency and therapy—from a veterinary perspective
DE69226980D1 (de) Rekombinanter Varicella-Zoster-Virus-Vektor
CA2116355A1 (en) Infectious bovine rhinotracheitis virus mutants and vaccines
ATE86119T1 (de) Lebendvaccine fuer ansteckungskrankheiten von kueken.
DK0606452T3 (da) Vektorvacciner fra rekombinant katteherpesvirus
ATE317439T1 (de) Virale vakzine
Nagesha et al. Analysis of the nucleotide sequence of five genes at the left end of the unique short region of the equine herpesvirus 4 genome
Gray et al. Viral isolates derived from simian varicella epizootics are genetically related but are distinct from other primate herpesviruses
EA200100720A1 (ru) Вирусная вакцина на основе делеционного вируса герпеса крупного рогатого скота типа 1 (bhv-1)
DE3787131D1 (de) Varicella-Zoster-Virus als lebende rekombinante Vakzine.
ES2132330T3 (es) Vacuna para la proteccion de caballos frente a la infeccion por el virus del herpes equino.
Becker Live Herpesvirus Vaccines: Serendipity or Engineering of the Virus Genome
種子野章 et al. Immunological properties of the cell-associated live infectious laryngotracheitis virus.
岡崎和子 et al. The immunodominant glycoprotein complex of equid herpesvirus 1 (EHV-1) and the counterpart of EHV-4.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees